April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
April 2012 Drug Information Update - Pharmacy Benefits ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
20 mL glass ampule, sterile pack (NDC 00409-4273-01)<br />
Marcaine 0.5%, Hospira<br />
10 mL vial, preservative-free (NDC 00409-1560-10)<br />
30 mL vial, preservative-free (NDC 00409-1560-29)<br />
50 mL vial, multi-dose (NDC 00409-1610-50)<br />
Sensorcaine 0.5%, APP<br />
10 mL vial, preservative-free (NDC 63323-0466-17)<br />
30 mL vial, preservative-free (NDC 63323-0466-37)<br />
30 mL vial, preservative-free, sterile pack (NDC 63323-0466-31)<br />
50 mL vial, multi-dose (NDC 63323-0467-57)<br />
Bupivacaine 0.75%<br />
Bupivacaine 0.75%, Hospira<br />
10 mL vial, preservative-free (NDC 00409-1165-01)<br />
30 mL vial, preservative-free (NDC 00409-1165-02)<br />
Marcaine 0.75%, Hospira<br />
10 mL vial, preservative-free (NDC 00409-1582-10)<br />
30 mL vial, preservative-free (NDC 00409-1582-29)<br />
Sensorcaine 0.75%, APP<br />
10 mL vial, preservative-free (NDC 63323-0472-17)<br />
30 mL vial, preservative-free (NDC 63323-0460-37)<br />
Reason for the Shortage<br />
• APP has Sensorcaine on shortage due to increased demand for the product.<br />
• Hospira has bupivacaine and Marcaine on shortage due to manufacturing delays.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=864<br />
Source: www.ashp.org<br />
Terbutaline Sulfate Injection<br />
March 28, <strong>2012</strong><br />
Products Affected - Description<br />
Terbutaline sulfate injection, 1 mg/mL, Akorn<br />
1 mL ampule (NDC 17478-0933-01)<br />
Terbutaline sulfate injection, 1 mg/mL, Bedford<br />
1 mL vial, package of 10 (NDC 55390-0101-10)<br />
1 mL Novaplus vial, package of 10 (NDC 55390-0193-10)<br />
Reason for the Shortage<br />
• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011.<br />
Product will become available in stages as production resumes.<br />
• Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories<br />
manufactured products. Availability of products is updated on the Bedford Laboratories website.<br />
• Akorn cannot provide a reason for the shortage.<br />
Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=808<br />
Source: www.ashp.org<br />
Ropivacaine Injection<br />
March 28, <strong>2012</strong><br />
Products Affected - Description<br />
Naropin Injection, 2 mg/mL, APP<br />
10 mL ampule, sterile pack (NDC 63323-0285-10)<br />
65
Change language